Novel resin design enables efficient enrichment of full AAV capsids by anion exchange chromatography

Cell & Gene Therapy Insights 2026; 12(6), 589–598

DOI: 10.18609/cgti.2026.072

Published: 16 July
Innovator Insight
Martin Liao


Key findings

  • The HiPer QA resin achieves high salt tolerance and resolution of empty and full AAV capsids
  • The purpose-built QA resin demonstrates lot-to-lot consistency, resulting in improved development costs
  • Resin performance remains consistent regardless of flow rate, while also maintaining AAV separation efficiency even with 15 seconds residence time
  • The HiPer QA resin enables efficient separation of AAV9 variants under high-conductivity buffer conditions

Summary

  • The micrometer-scale pore size of the resin improves pore accessibility for large biomolecules such as AAVs
  • The purpose-built QA resin enables rapid polishing of different AAV serotypes, minimizing the residence time and reducing the risk of capsid degradation
  • Purification conditions can be applied across multiple lots of resin, helping manufacturers manage development costs
What you will learn
01
Current challenges with conventional resins and monoliths in large biomolecule purification
02
How the micrometer-scale pore structure allows convective flow and pore-accessibility for large biomolecules
03
How the features of this resin platform support efficient enrichment of full AAV capsids
Key interests
AAV purification Anion exchange chromatography Empty/full capsid separation HiPer QA resin Lot-to-lot consistency Scale-up Gene therapy manufacturing